LOUISVILLE, Ky. / Sep 30, 2024 / Business Wire / In advance of Health Literacy Month, CenterWell™ launches CenterWell Presents and Conviva on Demand, libraries of online health information designed as additional resources seniors can use to improve their well-being. The free, online educational material includes live webinars and recorded videos on a variety of senior-focused health topics available at any time to anyone, whether or not they’re a CenterWell Senior Primary Care or Conviva Care Center patient.
The libraries’ content ranges from understanding blood pressure and arthritis to developing sleep habits that improve brain health and managing medications for chronic diseases. Seniors can choose to view more than 60 pieces of health education content (recorded videos, flyers) or sign up for live webinars offered twice a month. Participants have the opportunity to interact with health educators during the live airing of webinars.
“Our centers are often located in underserved areas where seniors may be challenged with access to health care and health education,” said Vivek Garg, M.D., Chief Medical Officer for CenterWell Senior Primary Care and Conviva Care Center. “Working with patients to improve their health literacy may help them overcome barriers to care, paving the way for a more equitable health care journey and improved health outcomes.”
CenterWell Senior Primary Care is the largest, fastest-growing senior-focused primary care provider in the country. Together with its sister brand Conviva Care Center, the organizations deliver care to about 332,000 seniors in nearly 300 centers as of June 30, 2024. Centers are open in 15 states with plans to add 30-50 new centers per year through 2025.
CenterWell is committed to treating the “whole person,” which includes caring not only for patients’ physical and mental health, but also addressing environmental factors that influence health. CenterWell Presents and Conviva on Demand are added resources to help seniors live their healthiest lives possible.
“We know that about 80% of seniors have at least one chronic condition, while approximately 50% have two or more,” Dr. Garg said. “These libraries of webinars and online resources can enhance their health education, reinforce their doctor’s medical advice and care team’s expertise, and encourage healthy habits at home.”
Interested seniors can visit https://www.centerwellprimarycare.com/en/resources/online-programs.html to learn more about CenterWell Presents’ health video offerings and https://www.convivacarecenters.com/en/resources/online-programs.html to learn more about Conviva on Demand’s offerings. To find a center near you, visit CenterWellPrimaryCare.com or ConvivaCareCenters.com.
About CenterWell
CenterWell is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and, most of all, personalized. As the largest provider of senior-focused primary care, one of the leading providers of home health care, and a leading integrated home delivery, specialty, hospice, and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.
Last Trade: | US$260.69 |
Daily Change: | 2.92 1.13 |
Daily Volume: | 153,981 |
Market Cap: | US$31.390B |
October 30, 2024 October 24, 2024 October 23, 2024 August 19, 2024 August 08, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB